1. Home
  2. PRTH vs CRVS Comparison

PRTH vs CRVS Comparison

Compare PRTH & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Priority Technology Holdings Inc.

PRTH

Priority Technology Holdings Inc.

HOLD

Current Price

$5.59

Market Cap

545.8M

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$8.38

Market Cap

634.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTH
CRVS
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
545.8M
634.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PRTH
CRVS
Price
$5.59
$8.38
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$8.00
$13.75
AVG Volume (30 Days)
553.8K
1.1M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$932,948,000.00
N/A
Revenue This Year
$10.60
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
$10.73
N/A
Revenue Growth
9.51
N/A
52 Week Low
$4.44
$2.54
52 Week High
$12.47
$9.60

Technical Indicators

Market Signals
Indicator
PRTH
CRVS
Relative Strength Index (RSI) 44.21 50.42
Support Level $5.45 $8.31
Resistance Level $5.94 $9.60
Average True Range (ATR) 0.24 0.54
MACD 0.06 -0.09
Stochastic Oscillator 22.73 23.25

Price Performance

Historical Comparison
PRTH
CRVS

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: